Press releases

New order from China

Regulatory

Bactiguard has received an initial order for coating concentrate from Well Lead Medical (Well Lead) in China. The order will be delivered promptly and generate license revenues in the fourth quarter 2020 of approximately SEK 9 million. In parallel with the marketing and sales of Bactiguard's BIP Foley...

Interim report for Q3 2020

Regulatory

Weak quarter but the need for infection prevention greater than ever. Third quarter (July-September 2020) Revenues amounted to SEK 34,1 (67,2) million a decreased by 49% (adjusted for currency -46%) due to Covid-19 effects on both license and BIP revenues. In addition, no new license revenue was generated within the quarter while the third...

Bactiguard maintains clear growth strategy and updates financial targets

Regulatory

Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020.Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's technology, with a focus on new license agreements and a broader product portfolio. “We are...

Nomination Committee appointed for the Annual General Meeting 2021

Regulatory

The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Wednesday 28 April 2021 at the company’s headoffice in Botkyrka, has been appoined. The Nomination Committee for the 2021 AGM in Bactiguard Holding AB (publ) will consist of the following members: Helena Borglund, appointed by KK Invest...

Interim report for Q2 2020

Regulatory

Strong growth and earnings development in quarter affected by COVID-19 Second quarter (April-June 2020) Revenues amounted to SEK 48,2 (33,0) million and increased by 46% (adjusted for currency 45%). EBITDA amounted to SEK 10,5 (5,7) million with an EBITDA-margin of 22% (17%). Operating profit amounted to SEK -0,8 (-4,8) million. Net profit/loss...

Bactiguard initiates collaboration with online pharmacy Apotea on sales of Hydrocyn® aqua

Regulatory

Bactiguard initiates collaboration with the online pharmacy Apotea on sales of Hydrocyn® aqua (Hydrocyn) to consumers in the Swedish market. Recent tests confirm that Hydrocyn is the first disinfectant on the Swedish market with documentet effect on the new Corona virus causing COVID-19. Sales via Apotea will commence on 5 June. “We are...

Hydrocyn® aqua inactivates the coronavirus causing COVID-19

Regulatory

The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bactiguard launched Hydrocyn in the Swedish market in March, with focus on critical societal...

Increased number of shares and votes in Bactiguard

Regulatory

During May 2020, the number of class B shares in Bactiguard Holding AB (publ) ("Bactiguard") has increased by 241,512. As a result, the total number of shares in the company as of May 29, 2020 amounted to 29,543,885 and the total number of votes to 69,543,885.The increase is a result of the new issue of shares by way of set-off that was approved...

Interim report for Q1 2020

Regulatory

The development of the Covid-19 pandemic has painfully highlighted the urgent need for infection prevention. This has led to an increased interest in Bactiguard and generated strong sales from mid-March. Total revenues increased by more than 40 percent in the quarter and EBITDA doubled, generating an EBITDA margin of 30 percent and a positive net...

Bactiguard appoints Gabriella Björknert Caracciolo as new CFO

Regulatory

Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo, currently Head of Strategy, Development and Governance within Transaction Banking, Nordea as new CFO and Executive Vice President. She succeeds Cecilia Edström, who in February was appointed CEO of the company. Gabriella Björknert Caracciolo assumes her new position in...

Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting

Regulatory

At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 28 April, 2020, the following resolutions were made:The AGM adopted the income statements and balance sheets for 2019 and decided that no dividend for the financial year 2019 will be paid. Share premium reserve, retained earnings and the company's loss for the year will be carried...

Information about the Annual General Meeting 2020 and invitation to CEO presentation

Regulatory

The Annual General Meeting will be held on Tuesday, 28 April 2020 at 2:00 pm at the company´s head office at Alfred Nobels Allé 150 in Tullinge. Due to the outbreak of the Covid-19 virus and for the safety of Bactiguard shareholders, the company urges all shareholders not to participate personally, but instead take advantage of the opportunity...

Bactiguard’s Annual Report 2019

Regulatory

The annual report for Bactiguard Holding AB (publ) 2019 is now available at www.bactiguard.com The annual report in Swedish is now available as a downloadable PDF document. An English version will be available shortly. A printed version of the report will be available from April 28 and can be ordered by email to: info@bactiguard.se. This...

Notice to attend the Annual General Meeting of Bactiguard Holding AB

Regulatory

The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual General Meeting to be held on Tuesday, 28 April 2020 at 2:00 pm at the company´s head office at Alfred Nobels Allé 150 in Tullinge. Registration will commence at 1 pm. Right to participate and notice of...

Year-end report 2019 Bactiguard Holding AB

Regulatory

A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that our growth strategy works.Fourth quarter (October-December 2019) Revenues amounted to SEK 61.6...

Christian Kinch resigns as CEO of Bactiguard and is proposed as new Chairman of the Board. Cecilia Edström appointed new CEO.

Regulatory

Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEO Cecilia Edström as new CEO of Bactiguard and Stefan Grass (CMO) as Deputy CEO. Until a permanent CFO has been recruited, Financial manager Lina Arverud will hold the position...

Bactiguard makes its first acquisition by acquiring Vigilenz

Regulatory

Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard’s position in infection control and wound management, as well as innovation and product development capability and capacity. The...